Related Experiment Video

Updated: Dec 24, 2025

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

1.5K

Antidiabetic therapy at admission and survival in diabetic patients with acute myocardial infarction

José Pedro L Nunes1,2, Filipa Melão2, Ana Rita Godinho2

  • 1Faculdade de Medicina da Universidade do Porto, Porto, Portugal.

Porto Biomedical Journal
|April 8, 2020
PubMed

Insights

This study found no difference in survival for myocardial infarction patients using dipeptidyl peptidase-4 (DPP-4) inhibitors. Survival outcomes were analyzed for diabetic patients admitted with acute myocardial infarction.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Diabetes mellitus frequently co-occurs with cardiovascular disease.
  • Patients with diabetes admitted for acute myocardial infarction (AMI) were analyzed.
  • The study investigated the impact of anti-diabetic medications on long-term survival.

Purpose of the Study:

  • To evaluate the association between anti-diabetic drugs used at admission and survival in diabetic patients with AMI.
  • To assess survival rates at 36 to 52 months post-admission.
  • To specifically examine the role of dipeptidyl peptidase-4 (DPP-4) inhibitors.

Main Methods:

  • Retrospective study utilizing electronic health records.
  • Analysis of data from 195 patient admissions for acute myocardial infarction.
  • Kaplan-Meier and Cox regression analyses were employed.

Main Results:

  • No significant difference in survival was observed for patients using DPP-4 inhibitors (n=35).
  • Metformin (n=92) showed a non-significant trend towards increased survival.
  • Insulin (n=51) and sulfonylureas (n=51) showed non-significant trends towards decreased survival.

Conclusions:

  • DPP-4 inhibitor use at admission did not alter survival in diabetic patients hospitalized for AMI.
  • The findings suggest that DPP-4 inhibitors may not impact long-term survival in this patient cohort.
  • Further research may be needed to explore survival trends with other anti-diabetic agents.
Abstract

Keywords:
Acute myocardial infarctionDPP-4 inhibitorsDiabetes mellitusSulfonylureas

More Related Videos

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

496
Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.2K

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
170
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
785
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
188
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
121
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
582
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
146